论文部分内容阅读
美国政府为应对日趋严峻的生物恐怖威胁,出台了一系列针对生化袭击的法规和研究计划。本文研究了以生物盾牌计划为核心的美国国家生物防御应对策略及其衍生计划,包括卫生与公众服务部(DHHS)/生物医学高级研究发展局(BARDA)生物恐怖应对计划及预算方案、以疾控中心(CDC)病原体清单为基础的顶级核化生威胁对策方案及其他重要病原体生物防御治疗研究计划等。分析了目前以上述研究为依托纳入国家战略储备体系的药物及研发趋势。
In response to the increasingly serious threat of biological terrorism, the U.S. government has promulgated a series of laws, regulations and research plans aimed at combating biochemical attacks. This article examines the US national biodefense coping strategies and their derivatives that center on the Biological Shield Program, including the DHHS / BARDA Bioterrorism Response Plan and Budget Program, Control Center (CDC) pathogen list based on the top nuclear threat programs and other important pathogen biological defensive treatment plan. Analyzed the current drug-based research and development trend of the national strategic reserve system based on the above research.